Mona S. Jhaveri-Brown
Corporate Officer/Principal en National Cancer Institute .
Perfil
Mona S.
Jhaveri-Brown is Founder and Chief Executive Officer of Foligo Therapeutics, Inc. she is a Member of National Cancer Institute.
Dr. Jhaveri-Brown received a PhD in Biochemistry from Wake Forest University.
Cargos activos de Mona S. Jhaveri-Brown
Empresas | Cargo | Inicio |
---|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 27/05/2009 |
Antiguos cargos conocidos de Mona S. Jhaveri-Brown.
Empresas | Cargo | Fin |
---|---|---|
Foligo Therapeutics, Inc.
Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Director Ejecutivo | - |
Formación de Mona S. Jhaveri-Brown.
Wake Forest University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Foligo Therapeutics, Inc.
Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Bolsa de valores
- Insiders
- Mona S. Jhaveri-Brown